Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Phase III Study of Short-term Radiotherapy Plus CAPOX and Short-term Radiotherapy Plus CAPOXIRI as Preoperative Treatment for Locally Advanced Rectal Cancer

NCT05646511 is registered in ClinicalTrials.gov with National Cancer Center Hospital East as lead sponsor.

NCT NCT05646511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05646511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Phase III Study of Short-term Radiotherapy Plus CAPOX and Short-term Radiotherapy Plus CAPOXIRI as Preoperative Treatment for Locally Advanced Rectal Cancer
Lead sponsor
National Cancer Center Hospital East
Phase
Phase 3
Overall status
Recruiting
Start date
November 21, 2022
Completion date
December 31, 2030
Enrollment
608 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer